Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Careers
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
01/18/05 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
51
01/18/05 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.17
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
59
01/18/05 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT 3
12/22/03 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23
EX-23
EX-31
EX-31
EX-32
EX-32
51
02/13/03 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23
EX-23
EX-99
EX-99
49
01/29/03 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT 3
01/29/02 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-10.14
EX-10.15
EX-23.1
48
02/01/01 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
35
01/29/01 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
35
01/28/00 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-21
EX-23.1
EX-27
EX-99.1
60
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Jan 13, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

Read More...
Jan 5, 2021

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

Read More...
Dec 21, 2020

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

Read More...
Copyrights © 2021 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap